RMTI Rockwell Medical Inc
Rockwell Medical Inc is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease with its products and services for the treatment of iron deficiency, secondary hyperparathyroidism, and hemodialysis.
$1.67
As of 05/20/2022 IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
Common stocksCategory3:
Micro cap
GICS sector: Health Care
Industry: Drug Manufacturers—Specialty &
Index country: USA
Country of incorporation: USA
IPO date: 03/05/2001
Outstanding shares: 93,986,470
Average volume: 349,829
Market cap: $167,295,917
Current dividend yield: 0.00%
All SEC filings:
SEC Edgar Online
Quarterly filings:
10-Q
Annual filings:
10-K
Sedol:
Valuation (See tab for details)
PE ratio: 0.00
PB ratio: 0.00
PS ratio: 0.00
Return on equity: 0.00%
Net income %: 0.00%